CA2585760A1 - Ophthalmic solution - Google Patents

Ophthalmic solution Download PDF

Info

Publication number
CA2585760A1
CA2585760A1 CA002585760A CA2585760A CA2585760A1 CA 2585760 A1 CA2585760 A1 CA 2585760A1 CA 002585760 A CA002585760 A CA 002585760A CA 2585760 A CA2585760 A CA 2585760A CA 2585760 A1 CA2585760 A1 CA 2585760A1
Authority
CA
Canada
Prior art keywords
ophthalmic composition
agent
antimicrobial agent
amount ranging
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002585760A
Other languages
English (en)
French (fr)
Inventor
Charles H. Powell
Stanley W. Huth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2585760A1 publication Critical patent/CA2585760A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/141—Biguanides, e.g. chlorhexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Eyeglasses (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002585760A 2004-11-09 2005-11-09 Ophthalmic solution Abandoned CA2585760A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62637104P 2004-11-09 2004-11-09
US60/626,371 2004-11-09
PCT/US2005/040827 WO2006053164A2 (en) 2004-11-09 2005-11-09 Ophthalmic solution

Publications (1)

Publication Number Publication Date
CA2585760A1 true CA2585760A1 (en) 2006-05-18

Family

ID=35848047

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002585760A Abandoned CA2585760A1 (en) 2004-11-09 2005-11-09 Ophthalmic solution

Country Status (8)

Country Link
US (1) US20060100173A1 (enExample)
EP (1) EP1809242B1 (enExample)
JP (1) JP2008519846A (enExample)
CN (1) CN101056614A (enExample)
AU (1) AU2005304424A1 (enExample)
CA (1) CA2585760A1 (enExample)
SG (1) SG157374A1 (enExample)
WO (1) WO2006053164A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20051569A1 (it) * 2005-08-11 2007-02-12 Biokosmes S R L Composizione cicatrizzante
US7456095B2 (en) * 2005-10-03 2008-11-25 International Business Machines Corporation Method and apparatus for forming nickel silicide with low defect density in FET devices
US20080152540A1 (en) * 2006-12-22 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
US9579341B2 (en) * 2007-05-16 2017-02-28 Johnson & Johnson Consumer Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
JP2009096790A (ja) * 2007-09-28 2009-05-07 Rohto Pharmaceut Co Ltd 疲れ目改善用及び／又はかすみ目改善用コンタクトレンズ装着液
US20090173045A1 (en) * 2008-01-09 2009-07-09 Yu-Chin Lai Packaging Solutions
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US20110046033A1 (en) * 2008-01-31 2011-02-24 Jinzhong Zhang Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US20100234319A1 (en) * 2009-03-11 2010-09-16 Abbott Medical Optics Inc. Complex of Polymeric Quaternary Ammonium and Anionic Polymers as a New Antimicrobial Agent for Ophthalmic Compositions
US8349303B1 (en) * 2009-04-29 2013-01-08 Bausch & Lomb Incorporated Polymeric quaternium compounds
JP5407688B2 (ja) * 2009-09-15 2014-02-05 日油株式会社 コンタクトレンズ用処理溶液
KR101134340B1 (ko) * 2011-06-10 2012-04-09 주식회사 휴온스 안과질환 예방 또는 치료용 점안제 조성물
JP4987170B1 (ja) 2011-09-02 2012-07-25 株式会社メニコン コンタクトレンズの親水性向上システム及びそれのコンタクトレンズ・パッケージングへの適用
LT2950783T (lt) * 2013-02-01 2019-10-25 Allergan Inc Dirbtinės ašaros, kurių sudėtyje yra natrio hialuronato ir karboksimetilceliuliozės
CN108024532A (zh) * 2015-07-24 2018-05-11 泰利福医疗公司 用于手术应用的抗微生物组合物
CN110392528A (zh) 2017-03-01 2019-10-29 埃科莱布美国股份有限公司 通过高分子量聚合物减少吸入危险的消毒剂和杀菌剂
US12419990B2 (en) * 2017-11-22 2025-09-23 Bausch & Lomb Incorporated Ophthalmic viscoelastic compositions
JP7304168B2 (ja) * 2018-02-23 2023-07-06 ロート製薬株式会社 点眼剤
EP3813583A1 (en) * 2018-06-27 2021-05-05 Bausch & Lomb Incorporated Packaging solutions
US11795320B2 (en) * 2019-09-20 2023-10-24 Bausch + Lomb Ireland Limited Grafted polymer and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1160505A (ja) * 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd 防腐組成物
KR100354606B1 (ko) * 2000-02-01 2002-09-30 주식회사 중외제약 다목적 콘택트 렌즈 관리 용액 조성물
IL156766A0 (en) * 2001-01-09 2004-02-08 Louis Johan Wagenaar Procedure and composition of treatment and/or care of the eye
WO2003072141A1 (en) * 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye

Also Published As

Publication number Publication date
SG157374A1 (en) 2009-12-29
WO2006053164A3 (en) 2006-08-10
WO2006053164A2 (en) 2006-05-18
CN101056614A (zh) 2007-10-17
EP1809242A2 (en) 2007-07-25
JP2008519846A (ja) 2008-06-12
US20060100173A1 (en) 2006-05-11
EP1809242B1 (en) 2013-03-20
AU2005304424A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
EP1809242B1 (en) Contact lens disinfection and packaging solution
CA2667426C (en) Biguanide composition with low terminal amine
CA2737263C (en) Mucomimetic compositions and uses therefore
EP2178571B1 (en) Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
EP1734923B1 (en) Zinc preservative composition and method of use
US7364723B1 (en) Liquid preparation for contact lenses
WO2021110975A1 (en) High hyaluronate multi-purpose disinfection solutions for ophthalmic applications
US20110257125A1 (en) Mucomimetic compositions and uses therefore
WO2014091574A1 (ja) 非イオン性ソフトコンタクトレンズ用消毒液
KR101644795B1 (ko) 불안정 음이온성 고분자전해질을 사용한 양이온성 살생물제의 상호작용 제어
JP4027060B2 (ja) コンタクトレンズ用洗浄保存液
JP4947895B2 (ja) コンタクトレンズケア用組成物
CA2548471A1 (en) Gentle preservative compositions for self-preserving solutions

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130501